Bill Wexler's Profits of DOOM Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Bill Wexler's Profits of DOOM

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bill Wexler who wrote ()	7/20/1998 10:45:00 PM
From: Bill Wexler	Read Replies (1) of 4634

The amazing Matt Geller - Oppenheimer analyst Much has been made about CIBC-Oppenheimer "analyst" Matt Geller's positive comments about Zonagen. Quite frankly, my parakeet is more qualified to analyze biotech companies than Mr. Geller. Mr. Geller belongs to that growing cadre of "analysts" that will always find some way to put a positive spin on even the most obvious scams. Mr. Geller's spotty and biased research should give investors pause before lending much credence to anything he says. In early April, Cor Therapeutics shot up on News of limited FDA approval of Integrelin (new indication). Mr. Geller immediately issued an upgrade (to "strong buy") as the stock rose from the low teens to the low twenties. Mr. Geller then set a $30 price target by the "end of the year". healthcarenewsserver.com What Mr. Geller conveniently neglected to do - much to the dismay of small investors who bought Corr at grossly inflated prices- was to mention the extremely limited market of Integrelin, even with the new indication. There was no way Cor could justify its market cap at those levels. Sure enough, the stock marched back down to the low teens (check a chart of CORR from early April to present). Mr. Geller's analysis of Zonagen is incorrect, and should be viewed with a great deal of skepticism by the small investor. Research material about Phentolamine and Zonagen's past shady activities - including the Immumax fraud, and its odd relationships with TXB and ARNX, are publicly available and should be studied carefully.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next